Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uraci

Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uraci

Item
http://www.wikidata.org/entity/Q34225481
Chemotherapy with enteric-coated tegafur/uracil for advanced hepatocellular carcinomaSecondary prevention of recurrence by interferon therapy after ablation therapy for hepatocellular carcinoma in chronic hepatitis C patientsStrategy for improving survival and reducing recurrence of HCV-related hepatocellular carcinomaRapid induction of orthotopic hepatocellular carcinoma in immune-competent rats by non-invasive ultrasound-guided cells implantation.Newer treatments for advanced hepatocellular carcinoma.Clinical features of hepatitis B virus-related hepatocellular carcinoma.Hepatic arterial infusion of chemotherapy for advanced hepatocellular carcinoma.Multidisciplinary treatments for hepatocellular carcinoma with major portal vein tumor thrombus.Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma.Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma.Models of hepatocellular carcinoma and biomarker strategy.Evaluation of safety parameters and changes in serum concentration in liver transplant recipients treated with doxorubicin during the anhepatic period.Surgical strategy for hepatocellular carcinoma patients with portal vein tumor thrombus based on prognostic factors.A randomized study of cisplatin and 5-FU hepatic arterial infusion chemotherapy with or without adriamycin for advanced hepatocellular carcinoma.
P2860

Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uraci

Item
http://www.wikidata.org/entity/Q34225481
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Improved survival for hepatoce ...... d enteric-coated tegafur/uraci
@ast
Improved survival for hepatoce ...... d enteric-coated tegafur/uraci
@en
Improved survival for hepatoce ...... d enteric-coated tegafur/uraci
@nl
type
label
Improved survival for hepatoce ...... d enteric-coated tegafur/uraci
@ast
Improved survival for hepatoce ...... d enteric-coated tegafur/uraci
@en
Improved survival for hepatoce ...... d enteric-coated tegafur/uraci
@nl
prefLabel
Improved survival for hepatoce ...... d enteric-coated tegafur/uraci
@ast
Improved survival for hepatoce ...... d enteric-coated tegafur/uraci
@en
Improved survival for hepatoce ...... d enteric-coated tegafur/uraci
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Improved survival for hepatoce ...... d enteric-coated tegafur/uraci
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932